Ignite Creation Date:
2024-05-06 @ 7:10 AM
Last Modification Date:
2024-10-26 @ 11:45 AM
Study NCT ID:
NCT02484872
Status:
UNKNOWN
Last Update Posted:
2021-08-23
First Post:
2015-06-24
Brief Title:
Has Inflammation a Significant Implication in Lung Cancer Evolution
Sponsor:
European Lung Cancer Working Party
Organization:
European Lung Cancer Working Party
Study Overview
Official Title:
LInflammation A-t-elle Une Implication Significative Dans lévolution du Cancer Bronchique
Status:
UNKNOWN
Status Verified Date:
2021-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Systemic inflammation is a potential prognostic factor in cancer Inflammation scores as the Glasgow score have been tested in cancer and specifically in lung cancer patients The aim of the study is to look at the prognostic and predictive value of inflammation during cancer evolution on the risk of complications leading to ICU admission and the risk of death
Detailed Description:
Patients with newly diagnosed lung cancer will be eligible All patients will have a blood sampling allowing testing inflammation and cytokine analyses at diagnosis during work-up and in case of complication
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None